Eureka Forbes Q1 FY27 Results: Revenue Growth and Exceptional Gains

Standalone Revenue: ₹700.77 Crore (Q1 FY27) vs ₹607.74 Crore (Q1 FY26)
Consolidated PAT: ₹56.99 Crore (Q1 FY27) vs ₹38.70 Crore (Q1 FY26)

Reader Takeaway: Steady revenue growth driven by operations, profits boosted by one-time exceptional gain. Watch Labour Code impact.

What just happened

Eureka Forbes Ltd. announced its financial results for the first quarter of Fiscal Year 2027. The company reported a standalone revenue of ₹700.77 crore, marking a 15.3% increase compared to ₹607.74 crore in the same quarter last year. Consolidated profit after tax (PAT) saw a significant jump of 47.3%, reaching ₹56.99 crore from ₹38.70 crore in Q1 FY26.

The substantial increase in PAT was partly due to an exceptional income of ₹19.54 crore. This arose from an amendment to the company's gratuity scheme to comply with the Payment of Gratuity Act, 1972, resulting in a reversal of gratuity expenses.

Why this matters

The revenue growth indicates sustained demand for Eureka Forbes' products. However, investors should note that the reported profit figures are significantly influenced by the one-time exceptional gain. While the core operations show strength, the underlying profitability without this exceptional item provides a clearer picture of business performance.

The backstory

Eureka Forbes is a well-known name in the health and hygiene segment. The company has been focusing on expanding its product portfolio and distribution network. Past financial periods have seen the company managing various operational and financial adjustments, including those related to employee benefits.

What changes now

While the current results show a healthy top-line growth, the one-time gain means that a direct year-on-year comparison of profit growth needs careful consideration. The company's focus remains on its core business segments.

Risks to watch

A key watch point for Eureka Forbes is the potential impact of the new Labour Codes, notified in November 2025. The company is actively monitoring these regulations for any future accounting adjustments, especially concerning retiral benefits. Regulatory risks related to the implementation of these codes are a key concern.

Management, Auditor, and Compliance Changes

The Q1 FY27 financial results were reviewed by the Audit Committee and approved by the Board of Directors on August 12, 2026. Deloitte Haskins & Sells LLP, the statutory auditor, provided a limited review report without any modifications. The auditor's report indicated reliance on other auditors for a subsidiary and management certifications for non-material subsidiaries.

Context metrics

Standalone Revenue for Q1 FY27 was ₹700.77 crore, up 15.3% from ₹607.74 crore in Q1 FY26.
Consolidated PAT for Q1 FY27 was ₹56.99 crore, up 47.3% from ₹38.70 crore in Q1 FY26.
Exceptional income from gratuity scheme amendment: ₹19.54 crore.